Vantis Vascular's CrossFAST System Revolutionizes Cardiac Procedures
Vantis Vascular Unveils CrossFAST System's Clinical Success
Vantis Vascular, a leading innovator in medical technology, has announced the impressive performance of its CrossFAST Integrated Microcatheter Advanced Delivery System. The system has excelled in ten intricate coronary interventional cases, marking a significant milestone in cardiac treatment.
Exceptional Performance in Complex Situations
Recently, the first commercial use of the CrossFAST System showcased its capabilities in performing complex high-risk coronary interventions (CHiP). This system was put to the test by Dr. Amir Kaki at St. John's Hospital, yielding outstanding results. Dr. Kaki noted the importance of specialized tools to navigate patients with complex conditions, particularly those with multiple comorbidities and challenging anatomical structures.
Advantages of the CrossFAST System
As Dr. Kaki explained, the CrossFAST Advanced Delivery System has revolutionized the approach to CHiP procedures. It proved its worth by enabling palliative stenting in difficult lesions, showcasing its unique ability to efficiently navigate tight and calcified vessels. This performance is attributed to its advanced design, which allows for smooth advancement amidst challenging environments.
A Revolutionary Class of Device
The CrossFAST System is distinguished as the first and only dual monorail microcatheter specifically developed for coronary and peripheral uses. Unlike traditional guide extension catheters that pose risks to vessels and previously placed stents, the CrossFAST incorporates an integrated microcatheter that facilitates safe transitions, thus minimizing adverse outcomes during catheter delivery.
Innovative Technology Behind CrossFAST
At the heart of the CrossFAST System is its DuoPROTM Interlocking Technology. This groundbreaking mechanism secures the microcatheter to the outer delivery catheter, allowing the system to function seamlessly as one entity. This design dramatically enhances pushability and navigation efficiency, addressing a frequent shortcoming of guide extension catheters, especially in high-risk scenarios.
Positive Reception from Medical Experts
Frank Saltiel, MD, Chief Clinical Officer for Vantis Vascular, expressed enthusiasm regarding the CrossFAST System's performance. He emphasized its ability to navigate challenging coronary anatomy effortlessly, suggesting that it could transform the approach to CHiP procedures. Dr. Saltiel is optimistic that CrossFAST will significantly improve treatment efficiency, reducing both procedure times and complications.
Availability of the CrossFAST System
The CrossFAST Integrated Microcatheter Advanced Delivery System is currently available in the United States through a limited market release, with a full release expected later. This development emphasizes Vantis Vascular's commitment to innovating within the field of cardiovascular treatment.
About Vantis Vascular
Vantis Vascular, Inc. is dedicated to pioneering advancements in vascular interventions. Established by a dedicated group of physicians, the company focuses on developing technologies designed to enhance treatment safety and effectiveness. Notable products include the innovative CrossFAST Integrated Microcatheter Advanced Delivery System and the CrossSHOCK™ Intravascular Lithotripsy (IVL) System, reflecting the company's emphasis on improving patient outcomes.
Frequently Asked Questions
What is the CrossFAST System?
The CrossFAST System is a specialized microcatheter designed for advanced coronary and peripheral vascular interventions, enhancing treatment delivery in complex cases.
Who developed the CrossFAST System?
Vantis Vascular, a medical technology company founded by physicians, created the CrossFAST System to innovate vascular interventions.
What were the outcomes of the initial use of CrossFAST?
The initial clinical uses showed a 100% success rate in procedures, with effective lesion targeting and no device-related complications.
When will the CrossFAST System be widely available?
The CrossFAST System is available through a limited release, with plans for a full market introduction in the near future.
What makes CrossFAST different from traditional guide extension catheters?
CrossFAST's design minimizes risks associated with traditional guide extension catheters, offering greater flexibility and safety in challenging vascular scenarios.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.
